Dtermin8n, I think you are a little off the mark!
In the last year we have license agreements with big companies like Agila and Novartis! If you think the science is dodgy, I suggest you take it up with these companies!
POH has licensed an injectable antibiotic product, harnessing its proprietary TPM® platform technology, to Agila Specialties Private Limited (Agila).
http://hotcopper.com.au/announcementFiles/2012/POH/cd92483d-5287-4552-bde1-5fceb20a3d31-POH381376.pdf
License and Supply Agreement between Themis Medicare Limited (“Themis”)and Novartis India Limited (“Novartis”), Themis has agreed to manufacture and supply and Novartis has agreed to purchase from Themis diclofenac topical gel
formulated using a unique TPM® transdermal drug delivery system, in finished dosage pharmaceutical form on certain commercial terms and conditions.
http://hotcopper.com.au/announcementFiles/2013/POH/2762871a-204a-4588-9b56-edf8fc196138-POH388341.pdf
Trade Safe!
- Forums
- ASX - By Stock
- AVE
- financial misappropriation ann is out
financial misappropriation ann is out, page-84
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.035K | 678.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39213269 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.002 |
31 | 73717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39213269 | 30 |
0.004 | 30014232 | 16 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 13.19pm 13/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online